We are live on
!
Find out more
ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
2 hedge funds and large institutions have $124K invested in ZyVersa Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.26% less ownership
Funds ownership: 0.26% → 0% (-0.26%)
93% less funds holding
Funds holding: 29 → 2 (-27)
93% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 29
100% less capital invested
Capital invested by funds: $74.3M → $124K (-$74.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
2
Holders Change
-27
Holders Change %
-93.1%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
29
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$537K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
+$123K |